207 related articles for article (PubMed ID: 10561208)
1. Sentinel lymph node biopsy with metastasis: can axillary dissection be avoided in some patients with breast cancer?
Reynolds C; Mick R; Donohue JH; Grant CS; Farley DR; Callans LS; Orel SG; Keeney GL; Lawton TJ; Czerniecki BJ
J Clin Oncol; 1999 Jun; 17(6):1720-6. PubMed ID: 10561208
[TBL] [Abstract][Full Text] [Related]
2. Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients.
Pendas S; Dauway E; Cox CE; Giuliano R; Ku NN; Schreiber RH; Reintgen DS
Am Surg; 1999 Jun; 65(6):500-5; discussion 505-6. PubMed ID: 10366202
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of the sentinel lymph node in breast cancer predict further involvement of higher-echelon nodes in the axilla: a study to evaluate the need for complete axillary lymph node dissection.
Kamath VJ; Giuliano R; Dauway EL; Cantor A; Berman C; Ku NN; Cox CE; Reintgen DS
Arch Surg; 2001 Jun; 136(6):688-92. PubMed ID: 11387010
[TBL] [Abstract][Full Text] [Related]
4. Nonsentinel lymph node status after positive sentinel lymph node biopsy in early breast cancer.
Saidi RF; Dudrick PS; Remine SG; Mittal VK
Am Surg; 2004 Feb; 70(2):101-5; discussion 105. PubMed ID: 15011910
[TBL] [Abstract][Full Text] [Related]
5. Factors predicting the non-sentinel lymph node involvement in breast cancer patients with sentinel lymph node metastases.
Boler DE; Uras C; Ince U; Cabioglu N
Breast; 2012 Aug; 21(4):518-23. PubMed ID: 22410110
[TBL] [Abstract][Full Text] [Related]
6. Sentinel lymphadenectomy without systematic axillary dissection in breast cancer patients: predictors of non-sentinel lymph node metastasis.
Travagli JP; Atallah D; Mathieu MC; Rochard F; Camatte S; Lumbroso J; Garbay JR; Rouzier R
Eur J Surg Oncol; 2003 May; 29(4):403-6. PubMed ID: 12711299
[TBL] [Abstract][Full Text] [Related]
7. Predicting the likelihood of additional nodal metastases in breast carcinoma patients with positive sentinel node biopsy.
Mustać E; Matusan-Ilijas K; Marijić B; Smokvina M; Jonjić N
Int J Surg Pathol; 2010 Feb; 18(1):36-41. PubMed ID: 19448065
[TBL] [Abstract][Full Text] [Related]
8. Number of lymph nodes removed in sentinel lymph node-negative breast cancer patients is significantly related to patient age and tumor size: a new source of bias in morbidity assessment?
Port ER; Patil S; Stempel M; Morrow M; Cody HS
Cancer; 2010 Apr; 116(8):1987-91. PubMed ID: 20151427
[TBL] [Abstract][Full Text] [Related]
9. Prediction of additional axillary metastasis of breast cancer following sentinel lymph node surgery.
Changsri C; Prakash S; Sandweiss L; Bose S
Breast J; 2004; 10(5):392-7. PubMed ID: 15327491
[TBL] [Abstract][Full Text] [Related]
10. A risk score model predictive of the presence of additional disease in the axilla in early-breast cancer patients with one or two metastatic sentinel lymph nodes.
Canavese G; Bruzzi P; Catturich A; Vecchio C; Tomei D; Del Mastro L; Carli F; Guenzi M; Lacopo F; Dozin B
Eur J Surg Oncol; 2014 Jul; 40(7):835-42. PubMed ID: 24684810
[TBL] [Abstract][Full Text] [Related]
11. Predictors of non-sentinel lymph node metastasis in breast cancer patients.
Goyal A; Douglas-Jones A; Newcombe RG; Mansel RE;
Eur J Cancer; 2004 Jul; 40(11):1731-7. PubMed ID: 15251163
[TBL] [Abstract][Full Text] [Related]
12. Intraoperative cytologic examination of breast sentinel lymph nodes: test utility and patient impact.
Dabbs DJ; Fung M; Johnson R
Breast J; 2004; 10(3):190-4. PubMed ID: 15125743
[TBL] [Abstract][Full Text] [Related]
13. Prediction of Extracapsular Invasion at Metastatic Sentinel Nodes and Non-sentinel Lymph Nodal Metastases by FDG-PET in Cases with Breast Cancer.
Fujii T; Yajima R; Tatsuki H; Kuwano H
Anticancer Res; 2016 Apr; 36(4):1785-9. PubMed ID: 27069160
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemistry with pancytokeratins improves the sensitivity of sentinel lymph node biopsy in patients with breast carcinoma.
Czerniecki BJ; Scheff AM; Callans LS; Spitz FR; Bedrosian I; Conant EF; Orel SG; Berlin J; Helsabeck C; Fraker DL; Reynolds C
Cancer; 1999 Mar; 85(5):1098-103. PubMed ID: 10091794
[TBL] [Abstract][Full Text] [Related]
15. Axillary node staging for microinvasive breast cancer: is it justified?
Lyons JM; Stempel M; Van Zee KJ; Cody HS
Ann Surg Oncol; 2012 Oct; 19(11):3416-21. PubMed ID: 22576061
[TBL] [Abstract][Full Text] [Related]
16. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
[TBL] [Abstract][Full Text] [Related]
17. Completion axillary lymph node dissection not required for regional control in patients with breast cancer who have micrometastases in a sentinel node.
Yegiyants S; Romero LM; Haigh PI; DiFronzo LA
Arch Surg; 2010 Jun; 145(6):564-9. PubMed ID: 20566977
[TBL] [Abstract][Full Text] [Related]
18. Predictors of tumour involvement in remaining axillary lymph nodes of breast cancer patients with positive sentinel lymph node.
Wada N; Imoto S; Yamauchi C; Hasebe T; Ochiai A
Eur J Surg Oncol; 2006 Feb; 32(1):29-33. PubMed ID: 16269227
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic features associated with having four or more metastatic axillary nodes in breast cancer patients with a positive sentinel lymph node.
Rivers AK; Griffith KA; Hunt KK; Degnim AC; Sabel MS; Diehl KM; Cimmino VM; Chang AE; Lucas PC; Newman LA
Ann Surg Oncol; 2006 Jan; 13(1):36-44. PubMed ID: 16378156
[TBL] [Abstract][Full Text] [Related]
20. Factors predicting non-sentinel lymph node metastasis in T1-2 invasive breast cancer with 1-2 axillary sentinel lymph node metastases: Presentation of Ondokuz Mayis scoring system.
Kuru B; Sullu Y; Yuruker S; Koray Bayrak I; Ozen N
J BUON; 2016; 21(5):1129-1136. PubMed ID: 27837614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
